Additive Solution Formula 3 | AS

13:35 EDT 17th September 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

AS-3 100 mL Catalog # 777965-000

Canada DIN 02324393

Intended for use only with Trima and Trima Accel automated red blood cell apheresis devices and Atreus Whole Blood Processing System. See Operator's Manuals for additional information and complete usage instructions.

Sterile. Non-pyrogenic. Do not use unless the solution is clear and the container is intact and undamaged. Rx only.

Single use container.

Caution: Not for direct intravenous infusion.

Room temperature.

Avoid excessive heat. Protect from freezing.

Each 100mL contains:

Dextrose Monohydrate USP 1.10   g
Sodium Citrate Dihydrate USP 0.588 g
Sodium Chloride USP 0.410 g
Monobasic Sodium Phosphate Monohydrate USP 0.276 g
Citric Acid Monohydrate USP 0.042 g
Adenine USP 0.030 g
In Water for Injection USP

LotExpiry Date

Manufactured for CaridianBCT, Inc., Lakewood CO 80215 by Ivex Pharmaceuticals, Larne, BT40 2SH, UK.

Dist. in Canada: CaridianBCT (Canada), Inc., 4 Robert Speck Pkwy,Ste. 1500, Mississauga, ON, Canada L4Z1S1

777965-054

Additive Solution Formula 3 AS-3

6 x 6 x 100mL unitsCatalog # 777965-000

Intended for use only with Trima and Trima Accel automated red blood cell apheresis devices and Atreus Whole Blood Processing System. See Operator's Manuals for additional information and complete usage instructions.

Sterile. Non-pyrogenic. Do not use unless the solution is clear and the container is intact and undamaged. Rx only. Single use container.

Caution: Not for direct intravenous infusion.

Recommended storage: Room temperature.Avoid excessive heat. Protect from freezing.

Each 100mL contains:

Lot Expiry Date

Manufactured for CaridianBCT, Inc., Lakewood CO 80215by Ivex Pharmaceuticals, Larne, BT40 2SH, UK.

Dist in Canada: CaridianBCT (Canada), Inc., 4 Robert Speck Pkwy,Ste. 1500, Mississauga, ON, Canada L4Z1S1Canada DIN 02324393777965-064

IMAGE as3-solution-01.jpg
Dextrose Monohydrate USP 1.10   g
Sodium Citrate Dihydrate USP 0.588 g
Sodium Chloride USP 0.410 g
Monobasic Sodium Phosphate Monohydrate USP 0.276 g
Citric Acid Monohydrate USP 0.042 g
Adenine USP 0.030 g
In Water for Injection USP

Manufacturer

CaridianBCT, Inc.

Active Ingredients

Source

Clinical Trials [66500 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Search BioPortfolio:
Loading
Advertisement
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record